Literature DB >> 23268425

Sub-lingual immunotherapy: world allergy organization position paper 2009.

G Walter Canonica, Jean Bousquet, Thomas Casale, Richard F Lockey, Carlos E Baena-Cagnani, Ruby Pawankar, Paul C Potter, Philippe J Bousquet, Linda S Cox, Stephen R Durham, Harold S Nelson, Giovanni Passalacqua, Dermot P Ryan, Jan L Brozek, Enrico Compalati, Ronald Dahl, Luis Delgado, Roy Gerth van Wijk, Richard G Gower, Dennis K Ledford, Nelson Rosario Filho, Erkka J Valovirta, Osman M Yusuf, Torsten Zuberbier.   

Abstract

Entities:  

Year:  2009        PMID: 23268425      PMCID: PMC3488881          DOI: 10.1097/WOX.0b013e3181c6c379

Source DB:  PubMed          Journal:  World Allergy Organ J        ISSN: 1939-4551            Impact factor:   4.084


× No keyword cloud information.
  347 in total

1.  Late side-effects during systemic immunotherapy in children.

Authors:  J-C Caubet; P A Eigenmann
Journal:  Allergy       Date:  2008-11       Impact factor: 13.146

Review 2.  Local immunotherapy.

Authors:  H J Malling; J Abreu-Nogueira; E Alvarez-Cuesta; B Björkstén; J Bousquet; D Caillot; G W Canonica; G Passalacqua; P Saxonis-Papageorgiou; E Valovirta
Journal:  Allergy       Date:  1998-10       Impact factor: 13.146

3.  Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.

Authors:  Ko-Huang Lue; Yung-Hsiang Lin; Hai-Lun Sun; Ko-Hsiu Lu; Jie-Cheng Hsieh; Ming-Chih Chou
Journal:  Pediatr Allergy Immunol       Date:  2006-09       Impact factor: 6.377

4.  How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?

Authors:  Kjetil Herland; Jan-Petter Akselsen; Ole Henning Skjønsberg; Leif Bjermer
Journal:  Respir Med       Date:  2005-01       Impact factor: 3.415

Review 5.  New visions in specific immunotherapy in children: an iPAC summary and future trends.

Authors:  Susanne Halken; Susanne Lau; Erkka Valovirta
Journal:  Pediatr Allergy Immunol       Date:  2008-08       Impact factor: 6.377

6.  Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study.

Authors:  E Nettis; M C Colanardi; A L Soccio; M Marcandrea; L Pinto; A Ferrannini; A Tursi; A Vacca
Journal:  Br J Dermatol       Date:  2007-04       Impact factor: 9.302

7.  Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients.

Authors:  P Bernardis; M Agnoletto; P Puccinelli; S Parmiani; M Pozzan
Journal:  J Investig Allergol Clin Immunol       Date:  1996 Jan-Feb       Impact factor: 4.333

8.  Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.

Authors:  Albrecht Bufe; Peter Eberle; Eivy Franke-Beckmann; Jürgen Funck; Martin Kimmig; Ludger Klimek; Roland Knecht; Volker Stephan; Bente Tholstrup; Christian Weisshaar; Friedrich Kaiser
Journal:  J Allergy Clin Immunol       Date:  2009-01       Impact factor: 10.793

9.  Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.

Authors:  N Mothes; M Heinzkill; K J Drachenberg; W R Sperr; M T Krauth; Y Majlesi; H Semper; P Valent; V Niederberger; D Kraft; R Valenta
Journal:  Clin Exp Allergy       Date:  2003-09       Impact factor: 5.018

10.  Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.

Authors:  Rauf Tahamiler; Gkioukxel Saritzali; Salih Canakcioglu
Journal:  Laryngoscope       Date:  2007-06       Impact factor: 3.325

View more
  27 in total

Review 1.  [Adherence in specific immunotherapy].

Authors:  M-L Lemberg; M-J Joisten; R Mösges
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

Review 2.  Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract.

Authors:  Hardik D Patel; Jeffrey M Chambliss; Meera R Gupta
Journal:  Curr Allergy Asthma Rep       Date:  2017-08-18       Impact factor: 4.806

Review 3.  The Future of Sublingual Immunotherapy in the United States.

Authors:  Nicole Pleskovic; Ashton Bartholow; Deborah A Gentile; David P Skoner
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

Review 4.  Immunotherapy in all aspects.

Authors:  Deniz Hanci; Ethem Şahin; Nuray Bayar Muluk; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-12       Impact factor: 2.503

5.  Negative clinical results from a randomised, double-blind, placebo-controlled trial evaluating the efficacy of two doses of immunologically enhanced, grass subcutaneous immunotherapy despite dose-dependent immunological response.

Authors:  Jörg Kleine-Tebbe; Mikkel Walmar; Klaus Bitsch-Jensen; Elke Decot; Oliver Pfaar; Dolores Hernández Fernández de Rojas; Fernando Rodriguez
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

Review 6.  Chinese Guideline on allergen immunotherapy for allergic rhinitis.

Authors:  Yixiao Bao; Jianjun Chen; Lei Cheng; Yinshi Guo; Suling Hong; Weijia Kong; He Lai; Houyong Li; Huabin Li; Jing Li; Tianying Li; Xiaoping Lin; Shixi Liu; Zheng Liu; Hongfei Lou; Juan Meng; Qianhui Qiu; Kunling Shen; Wei Tang; Zezhang Tao; Chengshuo Wang; Xiangdong Wang; Qingyu Wei; Li Xiang; Hua Xie; Yu Xu; Gehua Zhang; Yuan Zhang; Yiwu Zheng; Yuxiang Zhi; Dehua Chen; Haiyu Hong; Quansheng Li; Lin Liu; Yifan Meng; Nan Wang; Yihui Wang; Yue Zhou; Luo Zhang
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

7.  Sublingual immunotherapy: World Allergy Organization position paper 2013 update.

Authors:  Giorgio Walter Canonica; Linda Cox; Ruby Pawankar; Carlos E Baena-Cagnani; Michael Blaiss; Sergio Bonini; Jean Bousquet; Moises Calderón; Enrico Compalati; Stephen R Durham; Roy Gerth van Wijk; Désirée Larenas-Linnemann; Harold Nelson; Giovanni Passalacqua; Oliver Pfaar; Nelson Rosário; Dermot Ryan; Lanny Rosenwasser; Peter Schmid-Grendelmeier; Gianenrico Senna; Erkka Valovirta; Hugo Van Bever; Pakit Vichyanond; Ulrich Wahn; Osman Yusuf
Journal:  World Allergy Organ J       Date:  2014-03-28       Impact factor: 4.084

8.  Satisfaction of allergic patients treated with house dust mite sublingual immunotherapy.

Authors:  Matheus Fonseca Aarestrup; Paula Fonseca Aarestrup; Mariana Senff de Andrade; Beatriz Julião V Aarestrup; Akinori Cardozo Nagato; Fernando Monteiro Aarestrup
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

9.  History of the world allergy organization: innovation in continuity 2008-2009.

Authors:  Giorgio Walter Canonica
Journal:  World Allergy Organ J       Date:  2011-11-18       Impact factor: 4.084

10.  Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper.

Authors:  Giovanni Passalacqua; Enrico Compalati; Giorgio Walter Canonica
Journal:  World Allergy Organ J       Date:  2010-07       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.